Shares of Jazz Pharmaceuticals, Inc. JAZZ are higher on the session by 2.73%, trading at $29.35.
Overall call volume is now running at 2.34x the daily average, with 66% of all calls traded being purchases on the offer. 1,458 contracts have traded on the session so far.
Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focusing on the development and commercialization of pharmaceutical products to meet unmet medical needs in neurology and psychiatry.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in